Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children

AIDS

Volumn 28, Issue 11, 2014, Pages 1645-1655

  Desmonde, Sophie ^a,b   Dicko, Fatoumata ^c,ai   Koueta, Fla ^d   Eboua, Tanoh ^e   Balestre, Eric ^a,b   Amani Bosse, Clarisse ^f   Aka, Edmond A ^g   Lawson Evi, Koko ^h,aq   Amorissani Folquet, Madeleine ⁱ   Kouakou, Kouadio ^j   Koumakpai, Siriatou ^k   Renner, Lorna ^l,z   Signaté Sy, Haby ^m   Leroy, Valériane ^a,b   Zannou, Djimon Marcel ⁿ   Ahouada, Carin ⁿ   Akakpo, Jocelyn ⁿ   Ahomadegbé, Christelle ⁿ   Bashi, Jules ⁿ   Gougounon Houéto, Alice ⁿ   Azon Kouanou, Angèle ⁿ   Houngbé, Fabien ⁿ   Sehonou, Jean ⁿ   Koumakpaï, Sikiratou ⁿ   Alihonou, Florence ⁿ   D'Almeida, Marcelline ⁿ   Hodonou, Irvine ⁿ   Hounhoui, Ghislaine ⁿ   Sagbo, Gracien ⁿ   Tossa Bagnan, Leïla ⁿ   Adjide, Herman ⁿ   Drabo, Joseph ^o   Bognounou, René ^o   Dienderé, Arnaud ^o   Traore, Eliezer ^o   Zoungrana, Lassane ^o   Zerbo, Béatrice ^o   Sawadogo, Adrien Bruno ^p   Zoungrana, Jacques ^p   Héma, Arsène ^p   Soré, Ibrahim ^p   Bado, Guillaume ^p   Tapsoba, Achille ^p   Yé, Diarra ^q   Kouéta, Fla ^q   Ouedraogo, Sylvie ^q   Ouédraogo, Rasmata ^q   Hiembo, William ^q   Gansonré, Mady ^q   Messou, Eugène ^r   Gnokoro, Joachim Charles ^r   Koné, Mamadou ^r   Kouakou, Guillaume Martial ^r   Bosse, Clarisse Amani ^s   Brou, Kouakou ^s   Assi, Achi Isidore ^s   Chenal, Henri ^j   Hawerlander, Denise ^j   Soppi, Franck ^j   Minga, Albert ^t   Abo, Yao ^t   Yoboue, Jean Michel ^t   Eholié, Serge Paul ^u   Amego, Mensah Deborah Noelly ^u   Andavi, Viviane ^u   Diallo, Zelica ^u   Ello, Frédéric ^u   Tanon, Aristophane Koffi ^u   Koule, Serge Olivier ^u   Anzan, Koffi Charles ^u   Guehi, Calixte ^u   Aka, Edmond Addi ^v   Issouf, Koffi Ladji ^v   Kouakou, Jean Claude ^v   N'Gbeche, Marie Sylvie ^v   Pety, Touré ^w   Avit Edi, Divine ^w   Moh, Magloire ^j   Yao, Valérie Andoblé ^j   Folquet, Madeleine Amorissani ^x   Dainguy, Marie Evelyne ^x   Kouakou, Cyrille ^x   Méa Assande, Véronique Tanoh ^x   Oka Berete, Gladys ^x   Zobo, Nathalie ^x   Acquah, Patrick ^x   Kokora, Marie Berthe ^x   Eboua, Tanoh François ^y   Timité Konan, Marguerite ^y   Ahoussou, Lucrèce Diecket ^y   Assouan, Julie Kebé ^y   Sami, Mabéa Flora ^y   Kouadio, Clémence ^y   Goka, Bamenla ^z   Welbeck, Jennifer ^z   Sackey, Adziri ^z   Owiafe, Seth Ntiri ^z   Wejse, Christian ^aa   Da Silva, Zacarias José ^aa   Paulo, Joao ^aa   Rodrigues, Amabelia ^aa   Da Silva, David ^ab   Medina, Candida ^ac   Oliviera Souto, Ines ^aa   Østergaard, Lars ^ad   Laursen, Alex ^ad   Sodemann, Morten ^ae   Aaby, Peter ^aa   Fomsgaard, Anders ^af   Erikstrup, Christian ^ag   Eugen Olsen, Jesper ^ah   Maïga, Moussa Y ^ai   Diakité, Fatoumata Fofana ^ai   Kalle, Abdoulaye ^ai   Katile, Drissa ^ai   Traore, Hamar Alassane ^aj   Minta, Daouda ^aj   Cissé, Tidiani ^aj   Dembelé, Mamadou ^aj   Doumbia, Mohammed ^aj   Fomba, Mahamadou ^aj   Kaya, Assétou Soukho ^aj   Traoré, Abdoulaye M ^aj   Traoré, Hamady ^aj   Toure, Amadou Abathina ^aj   Sylla, Mariam ^ai   Berthé, Alima ^ai   Traoré, Hadizatou Coulibaly ^ai   Koïta, Anta ^ai   Koné, Niaboula ^ai   N'Diaye, Clémentine ^ai   Coulibaly, Safiatou Touré ^ai   Traoré, Mamadou ^ai   Traoré, Naïchata ^ai   Charurat, Man ^ak   Ajayi, Samuel ^al   Alim, Georgina ^al   Dapiap, Stephen ^al   Otu, ^al   Igbinoba, Festus ^am   Benson, Okwara ^an   Adebamowo, Clément ^an   James, Jesse ^an   Obaseki, ^an   Osakede, Philip ^an   Olasode, John ^ao   Seydi, Moussa ^ap   Sow, Papa Salif ^ap   Diop, Bernard ^ap   Manga, Noël Magloire ^ap   Tine, Judicael Malick ^ap   Bassabi, Coumba Cissé ^ap   Sy, Haby Signate ^ag   Ba, Abou ^ag   Diagne, Aida ^ag   Dior, Hélène ^ag   Faye, Malick ^ag   Gueye, Ramatoulaye Diagne ^ag   Mbaye, Aminata Diack ^ag   Patassi, Akessiwe ^aq   Kotosso, Awèrou ^aq   Kariyare, Benjamin Goilibe ^aq   Gbadamassi, Gafarou ^aq   Komi, Agbo ^aq   Mensah Zukong, Kankoé Edem ^aq   Pakpame, Pinuwe ^aq   Atakouma, Yawo ^aq   Takassi, Elom ^aq   Djeha, Améyo ^aq   Ephoévi Gah, Ayoko ^aq   El Hadj Djibril, Sherifa ^aq   Dabis, François ^a   Bissagnene, Emmanuel ^a   Arrivé, Elise ^a   Coffie, Patrick ^j   Ekouevi, Didier ^j   Jaquet, Antoine ^a   Lewden, Charlotte ^a   Sasco, Annie J ^a   Amani, Dieudonné ^j   Azani, Jean Claude ^j   Bessekon, Serge ^j   Bohossou, Franck ^j   Gilbert, Camille ^a   Karcher, Sophie ^a   Gonsan, Jules Mahan ^j   Le Carrou, Jérôme ^a   Lenaud, Séverin ^j   Nchot, Célestin ^j   Malateste, Karen ^a   Yao, Amon Roseamonde ^j   Siloué, Bertine ^j   Clouet, Gwenaelle ^a   Dosso, Madikona ^j   Doring, Alexandra ^a   Kouakou, Adrienne ^j   Rabourdin, Elodie ^a   Rivenc, Jean ^ag   Anglaret, Xavier ^a   Ba, Boubacar ^c   Becquet, Renaud ^a   Essanin, Jean Bosco ^g   Ciaranello, Andrea ^ag   Datté, Sébastien ^j   Diby, Jean Serge Elvis ^j   Gottlieb, Geoffrey S ^ag   Horo, Apollinaire Gninlgninrin ^j   Kangah, Serge N'Zoré ^j   Malvy, Denis ^a   Meless, David ^j   Mounkaila Harouna, Aida ^a   Ndondoki, Camille ^a   Shiboski, Caroline ^ag   Tchounga, Boris ^j   Thiébaut, Rodolphe ^a   Wandeler, Gilles ^m   more..

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c HÔPITAL GABRIEL TOURÉ   (Mali)

^d Centre Hospitalier Universitaire Pediatrique Charles de Gaulle   (Burkina Faso)

^e Centre Hospitalo Universitaire de Yopougon   (Côte d’Ivoire)

^f Programme MTCT+   (Côte d’Ivoire)

^g Centre de Prise en Charge de Recherche et de Formation (CePReF)   (Côte d’Ivoire)

^h UNIVERSITÉ DE LOMÉ   (Togo)

ⁱ Centre hospitalo universitaire de Cocody   (Côte d’Ivoire)

^j CIRBA   (Côte d’Ivoire)

^k Centre National Hospitalier Universitaire Hubert K Maga   (Benin)

^l Korle Bu Hospital   (Ghana)

^m Hôpital Pédiatrique Albert Royer   (Senegal)

ⁿ CNHU Hubert Maga   (Burkina Faso)

^o Service d'Urologie   (Burkina Faso)

^p CHU Souro Sanou   (Burkina Faso)

^q Charles De Gaulle Pediatric University Teaching Hospital   (Burkina Faso)

^r ACONDA CePReF   (Burkina Faso)

^s ACONDA MTCT Plus   (Burkina Faso)

^t CMSDS CNTS   (Côte d’Ivoire)

^u CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^v ACONDACePReF   (Côte d’Ivoire)

^w ACONDA MTCT Plus   (Côte d’Ivoire)

^x CHU de Cocody   (Côte d’Ivoire)

^y CHU Yopougon   (Côte d’Ivoire)

^z Korle Bu TH   (Ghana)

^aa BANDIM HEALTH PROJECT   (Guinea-Bissau)

^ab National HIV Program Bissau   (Guinea-Bissau)

^ac Simão Mendes National Hospital   (Guinea-Bissau)

^ad AARHUS UNIVERSITY HOSPITAL   (Denmark)

^ae ODENSE UNIVERSITY HOSPITAL   (Denmark)

^af STATENS SERUM INSTITUT   (Denmark)

^ag CH Gabriel Toure ^*  (United States)

^ah HVIDOVRE HOSPITAL   (Denmark)

^ai CH Gabriel Toure   (Nigeria)

^aj CH Point G   (Nigeria)

^ak UMB IHV   (Nigeria)

^al UATH   (Nigeria)

^am NATIONAL HOSPITAL   (Nigeria)

^an UBTH   (Nigeria)

^ao OATH Ile Ife   (Nigeria)

^ap SMIT CHU Fann   (Senegal)

^aq CHU Tokoin Sylvanus Olympio   (Togo)

more..

Author keywords

Antiretroviral therapy; Children; HIV; Immune reconstitution; West Africa

Indexed keywords

COTRIMOXAZOLE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; AFRICA; AGE; HIV INFECTIONS; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; SEX DIFFERENCE; TREATMENT OUTCOME;

AFRICA, WESTERN; AGE FACTORS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; SEX FACTORS; TREATMENT OUTCOME;

EID: 84904743260     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000272     Document Type: Article

References (32)

1. World Health Organisation. UNAIDS report on the global AIDS epidemic. UNAIDS; 2011.
2. Spira R, Lepage P, Msellati P, Van de Perre P, Leroy V, Simonon A, et al. Natural history of human immunodefiency virus type 1 infection in children: a five-year prospective study in Rwanda. Pediatrics 1999; 104: e56-e156.
3. Nathan LM, Nerlander LM, Dixon JR, Ripley RM, Barnabas R, Wholeben BE, et al. Growth, morbidity, and mortality in a cohort of institutionalized HIV-1-infected African children. J Acquir Immune Defic Syndr 2003; 34: 237-241.
4. Harambat J, Fassinou P, Becquet R, Touré P, Rouet F, Dabis F, et al. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study. BMC Public Health 2008; 8: 169-1169.
5. Desmonde S, Coffie P, Aka E, Amani-Bosse C, Messou E, Dabis F, et al. Severe morbidity and mortality in untreated HIVinfected children in a paediatric care programme in Abidjan, Cô te d'Ivoire, 2004-2009. BMC Infect Dis 2011; 11: 182-1182.
6. World Health Organisation. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2010 Revision. UNAIDS; 2010.
7. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary healthcare facilities in Zambia. JAMA 2007; 298: 1888-1899.
8. Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, Touré S, et al. Scaling up antiretroviral therapy for HIV-infected children in Cô te d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ 2010; 88: 490-499.
9. Davies MA, Keiser O, Technau K, Eley B, Rabie H, van Cutsem G, et al. Outcomes for the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. South Afri Med J 2010; 99: 730-737.
10. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al. Early antiretroviral therapy and mortality among HIVinfected infants. N Engl J Med 2008; 359: 2233-2244.
11. World Health Organization. Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting. Revised treatment recommendations for infants. Geneva: WHO. 2008.
12. World Health Organisation. The use of antiretroviral drugs for treating and preventing HIV infection. 2013.
13. Puthanakit T, Saphonn V, Ananworanich J, Kosalaraksa P, Hansudewechakul R, Vibol U, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis 2012; 12: 933-941.
14. Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr 2013; 62: 208-219.
15. Ekouevi DK, Azondekon A, Dicko F, Malateste K, Touré P, Eboua FT, et al. 12-month mortality and loss-To-program in antiretroviral-Treated children: the IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health 2011; 11: 519.
16. World Health Organisation. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Recommendations for a public health approach. UNAIDS; 2006.
17. Boyd K, Dunn DT, Castro H, Gibb DM, Duong T, Aboulker JP, et al. Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children. AIDS 2010; 24: 1213-1217.
18. World Health Organisation. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. UNAIDS 2007.
19. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364: 1236-1243.
20. Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, et al. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS Med 2013; 10: e1001555.
21. Brinkhof MWG, Spycher BD, Yiannoutsos C, Weigel R, Wood R, Messou E, et al. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa. PloS One 2010; 5: e14149-e14149.
22. Forster M, Bailey C, BrinkhofMW, Graber C, Boulle A, Spohr M, et al. Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ 2008; 86: 939-947.
23. Castelnuovo B, Kiragga A, Afayo V, Ncube M, Orama R, Magero S, et al. Implementation of provider-based electronic medical records and improvement of the quality of data in a large HIV program in Sub-Saharan Africa. PloS One 2012; 7: e51631.
24. Lewis J, Walker AS, Castro H, De Rossi A, Gibb DM, Giaquinto C, et al. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-Term T-cell reconstitution. J Infect Dis 2011; 205: 548-556.
25. Picat MQ, Lewis J, Musiime V, Prendergast A, Nathoo K, Kekitiinwa A, et al. Predicting patterns of long-Term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. PLoS Med 2013; 10: e1001542.
26. Newell ML, Patel D, Goetghebuer T, Thorne C. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation J Infect Dis 2006; 193: 954-962.
27. Patel K, Hernan MA, Williams PL, Seeger JD, McIntosh K, Dyke RB, et al. Long-Term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis 2008; 46: 1751-1760.
28. van Griensven J, Thai S. Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg 2011; 105: 694-703.
29. Puthanakit T, Aurpibul L, Oberdorfer P, Akarathum N, Kanjanavanit S, Wannarit P, et al. Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand. Pediatr Infect Dis J 2007; 26: 953-956.
30. Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Woerner I, Babiker A. Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. Lancet 2000; 355: 1331-1332.
31. Clerici M, Saresella M, Trabattoni D, Ferrante P, Vanzulli A, Vigano A. Thymic volume predicts long-Term immune reconstitution in HIV-infected children treated with highly active antiretroviral therapy. AIDS 2002; 16: 2219-2221.
32. Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E. Time to and predictors of CD4+ T-lymphocytes recovery in HIVinfected children initiating highly active antiretroviral therapy in Ghana. AIDS Res Treat 2011; 2011: 896040.